BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19285514)

  • 1. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
    Du QS; Huang RB; Wang CH; Li XM; Chou KC
    J Theor Biol; 2009 Jul; 259(1):159-64. PubMed ID: 19285514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.
    Huang RB; Du QS; Wang CH; Chou KC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1243-7. PubMed ID: 18996090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.
    Wang JF; Chou KC
    Protein Eng Des Sel; 2010 Aug; 23(8):663-6. PubMed ID: 20571121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers.
    Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M
    Nature; 2010 Feb; 463(7281):689-92. PubMed ID: 20130653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion channels: coughing up flu's proton channels.
    Miller C
    Nature; 2008 Jan; 451(7178):532-3. PubMed ID: 18235492
    [No Abstract]   [Full Text] [Related]  

  • 7. Free energy calculations on the two drug binding sites in the M2 proton channel.
    Gu RX; Liu LA; Wei DQ; Du JG; Liu L; Liu H
    J Am Chem Soc; 2011 Jul; 133(28):10817-25. PubMed ID: 21711026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the function and inhibition of an influenza virus proton channel.
    Stouffer AL; Acharya R; Salom D; Levine AS; Di Costanzo L; Soto CS; Tereshko V; Nanda V; Stayrook S; DeGrado WF
    Nature; 2008 Jan; 451(7178):596-9. PubMed ID: 18235504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
    Wang JF; Wei DQ; Chou KC
    Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does influenza virus a escape from amantadine?
    Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
    J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side-chain conformation of the M2 transmembrane peptide proton channel of influenza a virus from 19F solid-state NMR.
    Luo W; Mani R; Hong M
    J Phys Chem B; 2007 Sep; 111(36):10825-32. PubMed ID: 17705425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
    J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin].
    Kiselev OI; Mishin VP; Eroshkin VI; Kozeletskaia KN; Usova EV; Rudenko VI; Chupakhin ON
    Mol Biol (Mosk); 1994; 28(5):1009-13. PubMed ID: 7990823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.
    Khurana E; Devane RH; Dal Peraro M; Klein ML
    Biochim Biophys Acta; 2011 Feb; 1808(2):530-7. PubMed ID: 20385097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and mechanism of the M2 proton channel of influenza A virus.
    Schnell JR; Chou JJ
    Nature; 2008 Jan; 451(7178):591-5. PubMed ID: 18235503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method of resistance for influenza against a channel-blocking antiviral drug.
    Astrahan P; Kass I; Cooper MA; Arkin IT
    Proteins; 2004 May; 55(2):251-7. PubMed ID: 15048819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between an amantadine analogue and the transmembrane portion of the influenza A M2 protein in liposomes probed by 1H NMR spectroscopy of the ligand.
    Kolocouris A; Hansen RK; Broadhurst RW
    J Med Chem; 2004 Sep; 47(20):4975-8. PubMed ID: 15369403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
    Du QS; Huang RB; Wang SQ; Chou KC
    PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
    Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.